Leintz Pharmaceuticals And Chemicals Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 08-12-2024
- Paid Up Capital ₹ 4.65 M
as on 08-12-2024
- Company Age 19 Year, 8 Months
- Last Filing with ROC 31 Mar 2018
- Open Charges ₹ 2.75 Cr
as on 08-12-2024
- Revenue 24.22%
(FY 2018)
- Profit 1353.45%
(FY 2018)
- Ebitda -101.59%
(FY 2018)
- Net Worth 38.83%
(FY 2018)
- Total Assets -5.26%
(FY 2018)
About Leintz Pharmaceuticals And Chemicals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2018. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 4.65 M.
The company currently has active open charges totaling ₹2.75 Cr.
Sreenivasulu Yalavarthi, Venkateshwara Raju, and Padma Ramu serve as directors at the Company.
- CIN/LLPIN
U24232KA2005PTC036138
- Company No.
036138
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
21 Apr 2005
- Date of AGM
30 Sep 2018
- Date of Balance Sheet
31 Mar 2018
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- LocationBangalore., Karnataka
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Leintz Pharmaceuticals And Chemicals?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sreenivasulu Yalavarthi  | Director | 21-Apr-2005 | Current |
| Venkateshwara Raju | Director | 08-Mar-2014 | Current |
| Padma Ramu | Director | 08-Mar-2014 | Current |
Financial Performance of Leintz Pharmaceuticals And Chemicals.
Leintz Pharmaceuticals And Chemicals Private Limited, for the financial year ended 2018, experienced significant growth in revenue, with a 24.22% increase. The company also saw a substantial improvement in profitability, with a 1353.45% increase in profit. The company's net worth Soared by an impressive increase of 38.83%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Leintz Pharmaceuticals And Chemicals?
In 2018, Leintz Pharmaceuticals And Chemicals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Leintz Pneumatics Private LimitedActive 20 years 5 monthsSreenivasulu Yalavarthi is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 21 Aug 2018 | ₹1.50 Cr | Open |
Corporation Bank Creation Date: 15 Oct 2014 | ₹1.25 Cr | Open |
How Many Employees Work at Leintz Pharmaceuticals And Chemicals?
Unlock and access historical data on people associated with Leintz Pharmaceuticals And Chemicals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Leintz Pharmaceuticals And Chemicals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Leintz Pharmaceuticals And Chemicals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
